mesalamine has been researched along with folic acid in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Banatwala, N | 1 |
| Abdo, KM; Hart, RW; Iatropoulos, MJ; Kari, FW; Williams, GM | 1 |
| Croog, VJ; Itzkowitz, SH; Ullman, TA | 1 |
| Burakoff, R; Levine, JS | 1 |
| Pai, C; Sharif, O; Silverman, AL; Tang, J | 1 |
| Hibi, T; Yajima, T | 1 |
| Ardizzone, S; Danese, S; Gasche, C; Hernández, V; Kariv, R; Marti-Gallostra, M; Myrelid, P; Sebastian, S; Spinelli, A; Toruner, M; Tsianos, E; van der Meulen-de Jong, AE; Yuksel, ES | 1 |
| Han, SH; Lee, J | 1 |
| Brusač, E; Jeličić, ML; Klarić, DA; Mornar, A; Nigović, B; Turk, N | 1 |
| Bai, X; Chen, L; Lin, Y; Liu, Z; Luo, Z; Yang, R; Zhang, Z; Zhong, Z; Zhou, M | 1 |
6 review(s) available for mesalamine and folic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Drug Combinations; Drug Interactions; Enema; Female; Folic Acid; Glucosamine; Humans; Mesalamine; Pregnancy; Sulfapyridine; Sulfasalazine | 1985 |
Chemoprevention of colorectal cancer in ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium, Dietary; Chemoprevention; Cholagogues and Choleretics; Colitis, Ulcerative; Colorectal Neoplasms; Folic Acid; Hematinics; Humans; Mesalamine; Ursodeoxycholic Acid | 2003 |
Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colorectal Neoplasms; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Treatment Outcome; Ursodeoxycholic Acid; Vitamin B Complex | 2007 |
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).
Topics: Age of Onset; Anticarcinogenic Agents; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Congresses as Topic; Crohn Disease; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Mesalamine; Risk Factors; Survival Rate; Time Factors; Ursodeoxycholic Acid | 2014 |
[Chemoprevention of colorectal cancer in inflammatory bowel disease].
Topics: Anti-Inflammatory Agents; Chemoprevention; Colorectal Neoplasms; Folic Acid; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Ursodeoxycholic Acid | 2014 |
7 other study(ies) available for mesalamine and folic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Mechanistic studies on genotoxicity and carcinogenicity of salicylazosulfapyridine an anti-inflammatory medicine.
Topics: Aminosalicylic Acids; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Bone Marrow; Carcinogenicity Tests; DNA Adducts; Female; Folic Acid; Liver; Male; Mesalamine; Mice; Micronuclei, Chromosome-Defective; Mutagenicity Tests; Rats; Rats, Sprague-Dawley; Risk Assessment; Sulfapyridine; Sulfasalazine; Urinary Bladder | 1997 |
Mesalamine protects against colorectal cancer in inflammatory bowel disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Case-Control Studies; Chi-Square Distribution; Colorectal Neoplasms; Disease Progression; Female; Folic Acid; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Mesalamine; Middle Aged; Odds Ratio; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Treatment Outcome; Young Adult | 2010 |
[Chemoprevention of colorectal cancer associated with IBD].
Topics: Azathioprine; Colorectal Neoplasms; Crohn Disease; Folic Acid; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine | 2012 |
A chromatographic approach to development of 5-aminosalicylate/folic acid fixed-dose combinations for treatment of Crohn's disease and ulcerative colitis.
Topics: Chromatography; Colitis, Ulcerative; Crohn Disease; Drug Combinations; Folic Acid; Humans; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine | 2020 |
A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer.
Topics: Animals; Antineoplastic Agents; Butyric Acid; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclodextrins; Drug Delivery Systems; Folic Acid; Male; Mesalamine; Mice; Mice, Nude; Prodrugs | 2021 |